HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. It operates through the Cold Chain and Electronics business division. The Cold Chain business division refers to the distribution and sale of pharmaceutical products, including COVID-19 vaccines and influenza vaccines. The Electronics business division manufactures motors, pumps, and electronic components. The company was founded on June 7, 2000, and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company